Need Help: Providing Innovative and Sustainable Solutions, Call (+91) 6304126453
background

Oncology Intermediates

Our Services
Our Video!
background

Products

Oncology Intermediates

01

5-Deoxy-1,2,3-Tri-O-acetyl D-ribofuranoside

Cas.No: 62211-93-2
End User : Capecitabine Intermediates

02

2,3-Di-O-Acetyl-5-Deoxy-5-Fluoro Cytidine

Cas.No: 161599-46-8
End User : Capecitabine Intermediates

03

5-deoxi-5-fluoro-N-(pentyloxy)carbonyl cytidine

Cas.No: 162204-20-8
End User : Capecitabine Intermediates

04

5-Amino-2-methyl benzene sulfonamide

Cas.No: 6973-09-7
End User : Pazopanib Intermediates

05

2,3-Dimethyl-2H-Indazole6-amine Hydrochloride

Cas.No: 635702-60-2
End User : Pazopanib Intermediates

6

3-Amino-5-(4-phenoxyphenyl)-(1H)-pyrazole-4-carbonitrile

Cas.No: 330792-70-6
End User : Ibrutinib Intermediates

07

3-(4-Phenoxyphenyl)-1Hpyrazolo[3,4-d]pyrimidin4-amine

Cas.No: 330786-24-8
End User : Ibrutinib Intermediates

08

4-chloro-7-Methoxyquinoline-6-carboxaMide

Cas.No: 417721-36-9
End User : Lenvatinib Intermediates

09

2-Amino-N-(2-chloro6-methylphenyl)thiazole-5-carboxamide

Cas.No: 302964-24-5
End User : Dasatinib Intermediates

10

                4,6-Dichloro-2-methylpyrimidine
 

Cas.No: 1780-26-3
End User : Dasatinib Intermediates

11

N-[3-Chloro-4-(3-fluorobenzyloxy) phenyl]-6-iodoquinazolin-4-amine

Cas.No: 231278-20-9
End User : Lapatinib Intermediates

12

N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine

Cas.No: 162012-67-1
End User : Afatinib Intermediates

13

5-Formyl-2,4-dimethyl-1Hpyrrole-3-carboxylic acid

Cas.No: 253870-02-9
End User : Sunitinib Intermediates

14

2,3-Di-O-Acetyl-5-Deoxy-5-Fluoro Cytidine

Cas.No: 356068-86-5
End User : Sunitinib Intermediates

15

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid

Cas.No: 641569-94-0
End User : Nilotinib Intermediates

16

                Diethyl L-glutamatehydrochloride

Cas.No: 1118-89-4
End User : Pemetrexed Intermediates

17

N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide

Cas.No: 1139453-98-7
End User : Nintedanib Intermediates

18

N-(4-aminophenyl)-Nmethyl-2-(4-methylpiperazin-1-yl)acetamide

Cas.No: 262368-30-9
End User : Nintedanib Intermediates

19

Methyl 2-bromomethyl-3-nitrobenzoate       

Cas.No: 98475-07-1
End User : Lenalidomide Intermediates

20

2,6-Dioxopiperidine-3-ammonium chloride

Cas.No: 24666-56-6
End User : Lenalidomide Intermediates

21

3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione

Cas.No: 827026-45-9
End User : Lenalidomide Intermediates

22

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine

Cas.No: 152460-10-1
End User : Imatinib Intermediates

23

4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride

Cas.No: 106261-49-8
End User : Imatinib Intermediates

24

5-Formyl-2,4-dimethyl-1Hpyrrole-3-carboxylic acid

Cas.No: 253870-02-9
End User : Sunitinib Intermediates

25

N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1Hpyrrole-3-carboxamide

Cas.No: 356068-86-5
End User : Sunitinib Intermediates

26

tert-butyl 4-((E)-3-(dimethylamino) acryloyl) piperidine-1-carboxylate 98%

Cas.No: 960201-86-9 or 1799799-87-3
End User : Zanubrutinib Intermediates

27

3-Bromo-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Cas.No: 83255-86-1
End User : Sapatisertinib Intermediates

28

1-((4-Fluorophenyl)carbamoyl) cyclopropanecarboxylic acid

Cas.No: 849217-48-7
End User : Cabozantinib Intermediates

29

4-chloro-6,7-dimethoxyquinoline              

Cas.No: 35654-56-9
End User : Cabozantinib Intermediates

30